Combined Thrombectomy for Distal Medium Vessel Occlusion Stroke
584
about 3.7 years
18+
4 sites in GA, IA, OH +1
What this study is about
Researchers are testing whether endovascular thrombectomy, in addition to standard medical care, improves outcomes for people who have a stroke caused by a blockage in a small blood vessel in the brain. The trial will last for 1337 days and involve approximately 584 participants.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Standard medical management
- 2.Use Experimental: endovascular thrombectomy in patients who suffer a distal medium vessel occlusion
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Secondary: All cause mortality, Brain tissue reperfusion evaluated by CT or MRI perfusion at 24 hours in both treatment groups (if available), Cost effectiveness analysis of endovascular thrombectomy vs standard medical therapy, Final infarct growth (FIV - baseline infarct on CTP or DWI) evaluated on CT or MRI at 3-5 days (if available), Final infarct volume (FIV) (FIV - baseline infarct on CTP or DWI) evaluated on CT or MRI at 24 hours (-2/+12 hours), Final infarct volume (FIV) and infarct growth (FIV - baseline infarct on CTP or DWI) evaluated on CT or MRI at 3-5 days (if available), Patient reported outcomes ( IADL), Patient reported outcomes ( MoCa)
Neurology